Steady improvement in cancer survival
The highest 1-year cancer survival in men is for melanoma at 97.2% and the highest 5-year survival is for testicular cancer (95.9%), according to the latest figures from the Office of National Statistics (ONS).
Prostate cancer has the highest predicted 10-year survival for men diagnosed in 2016 at 82.9%.
Overall, cancer survival has been improving steadily in England but is still lower than similar countries in Europe and around the world, the document reports.
In men, pancreatic cancer had the lowest 1-year survival (22.9%) and 5-year survival was the lowest for mesothelioma (5.5%).
The largest difference in 1-year survival between men and women was for bladder cancer at 78.7% for men and 65.6% for women. This sex difference in bladder cancer survival has been reported worldwide and a number of reasons such as tumour biology, sex hormones and earlier diagnosis in men have been suggested to explain the difference, says the report.
Survival from prostate cancer was also very high (96.6% for all stages combined in 2015). There were no differences in 1-year survival between stages 1, 2 and 3. Survival in these three groups was higher than the general population. A lower survival was seen for stage 4 cancers but this was still higher than many other cancers diagnosed at earlier stages. 19% of prostate cancers are Stage 4 at diagnosis.
The proportion and number of cases diagnosed at each stage varies between different cancers and between men and women. Generally the data show that women are diagnosed at an earlier stage.